Twist Bioscience now appears more reasonably priced, which should lead to solid returns as fundamentals recover in H2 FY26.

Canadian-UK collaboration develops renewable bioplastic building blocks through advanced yeast fermentation for packaging ...

The growing importance of bioenergy and the role of research institutions in supporting its development was highlighted during a workshop on ‘Capacity building and awareness generation workshop on ...

Twist Bioscience Corp (TWST) reported its Q4 2025 earnings, revealing a larger-than-expected loss per share (EPS) of $0.45 against a forecasted loss of $0.41. Despite this, the company exceeded ...

Twist reported SynBio revenue of $39.5 million for the quarter, a 17% increase year-over-year, and $145 million for the full year. NGS revenue reached $53 million for the quarter and $208.1 million ...

SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Friday reported a loss of $27.1 million in its fiscal fourth quarter.